Linacre Quarterly, published by SAGE Publications Inc, is a distinguished journal that serves as an interdisciplinary platform in the fields of Health Policy and Philosophy. With an ISSN of 0024-3639 and an E-ISSN of 2050-8549, this journal has been pivotal in providing insights into the intricate dynamics of health policy through a philosophical lens since its inception in 1945. Notably, it holds a respectable 2023 Scopus rank, placing it in the 68th percentile within the Arts and Humanities (Philosophy) category and the 21st percentile in Medicine (Health Policy). Though currently not offering Open Access options, Linacre Quarterly remains committed to advancing scholarly discussion and fostering innovation among researchers, professionals, and students alike. Located in the United Kingdom, this journal continues to uphold its reputation as a vital resource for those navigating the complexities of health-related ethical dilemmas and policy-making frameworks, thereby enhancing its visibility and relevance in academic discourse.

BMC Medical Ethics is a leading open-access journal dedicated to the critical exploration and dissemination of knowledge surrounding ethical issues in healthcare and medicine. Published by BMC, and headquartered in the United Kingdom, this journal has become a cornerstone in the field since its inception in 2000, with a remarkable focus on health policy, nursing ethics, and the complex legal aspects intertwining with healthcare practices. With an impressive Q1 ranking across multiple categories, including Health Policy and Health (Social Science), it ranks among the top journals globally—particularly notable with its Scopus rankings reflecting a strong 85th percentile in Nursing and an 81st percentile in Social Sciences. As an open-access publication, BMC Medical Ethics ensures that research findings are readily accessible, fostering a collaborative environment for researchers, practitioners, and students alike. The journal's commitment to ethical discourse not only advances academic inquiry but also shapes the practices and policies that govern healthcare delivery; thus, making it an invaluable resource for those engaged in the advancement of medical ethics.

Christian Bioethics is a pivotal journal published by Oxford University Press, dedicated to the interdisciplinary exploration of bioethical issues from a Christian perspective. Since its inception in 1995, the journal has served as a crucial platform for scholars, practitioners, and students to engage with complex ethical questions at the intersection of medicine, philosophy, and religious studies. With an evolving scope that reflects contemporary debates in bioethics, the journal has achieved notable rankings, including Q2 in Religious Studies and Q3 in Philosophy in 2023, underscoring its significance in these fields. While not open access, Christian Bioethics continues to bridge gaps between faith and science, encouraging rigorous dialogue on how Christian ethics can inform bioethical decision-making and policy. It is essential reading for those looking to deepen their understanding of ethical issues shaped by religious convictions, making it an invaluable resource for researchers and professionals alike.

The HASTINGS CENTER REPORT, published by WILEY, is a leading journal in the fields of bioethics, health policy, and the philosophical underpinnings of healthcare. Established in 1971, this influential publication provides a critical platform for the discussion of ethical issues in health, medicine, and biotechnology, highlighting the intersection between ethical theory and practical health challenges. The journal achieves remarkable academic stature, achieving Q1 rankings in both Issues, Ethics and Legal Aspects and Philosophy, alongside Q2 standings in Health Policy and Health (social science) categories, reflecting its broad interdisciplinary impact. With its wide readership and rigorous peer-review process, the HASTINGS CENTER REPORT serves as an essential resource for researchers, practitioners, and students dedicated to advancing ethical perspectives in health-related discourse. While the journal operates under traditional access options, its contributions resonate deeply within the academic community, fostering informed dialogue on pressing ethical dilemmas and policy considerations in a rapidly evolving healthcare landscape.

THEORETICAL MEDICINE AND BIOETHICS, published by SPRINGER, is an esteemed journal dedicated to exploring the complex intersections of medicine, ethics, and law. With its ISSN 1386-7415 and E-ISSN 1573-1200, this journal serves as a vital platform for scholars, practitioners, and students interested in the ethical implications of medical practices and innovations. Although it currently holds a Q4 impact factor in the categories of Issues, Ethics and Legal Aspects and Medicine (Miscellaneous) as of 2023, its relevance is amplified by its commitment to fostering critical discourse in a rapidly evolving field. The journal features a diverse range of articles that address profound ethical dilemmas in healthcare, making it a significant resource for contemporary research from 1997 to the present. As an open-access journal, it ensures that cutting-edge knowledge is readily available, inviting contributions that challenge conventional thought and advance the field of bioethics.

New Bioethics: A Multidisciplinary Journal of Biotechnology and the Body, published by Taylor & Francis Ltd, serves as a pivotal platform for scholarly discourse at the intersection of biotechnology, health policy, and bioethics. With an ISSN of 2050-2877 and E-ISSN 2050-2885, this journal has been contributing to the academic community since its establishment in 2012 and is set to continue through 2024. It holds notable rankings in prestigious fields, including Q4 in Genetics (clinical), Q3 in Health Policy, Q2 in Issues, Ethics and Legal Aspects, and Q3 in Reproductive Medicine as per 2023 quartile indicators. Although no open access model is available, the journal remains an essential resource for those interested in the ethical implications of biotechnological advancements. Its focus on the ethical, legal, and social dimensions of biotechnology is particularly relevant in today's rapidly evolving scientific landscape, making it invaluable for researchers, professionals, and students keen to explore the complexities surrounding the biotechnology and the human condition.

BioLaw Journal-Rivista di Biodiritto, published by UNIV TRENTO, FAC LAW, stands as a vital interdisciplinary platform in the domains of biolaw, biotechnology, and health policy. With an ISSN of 2284-4503 and a burgeoning reputation, this journal encourages critical discussions surrounding the ethical, legal, and social implications of biotechnological advancements from 2014 to 2024. Ranked Q3 in both Biochemistry and Biotechnology, alongside Q2 rankings in Law and Philosophy, it reflects a growing body of scholarship in these experimental fields. Although currently categorized with varying percentile ranks in the Scopus database, it underlines the journal's commitment to nurturing innovative research and interdisciplinary dialogue. The journal promotes open access principles, although the specific access options should be verified for each article. It serves as an indispensable resource for researchers, professionals, and students engaged in the evolving intersection of law and biotechnology, making it a key player in shaping future discourses in bioethics and policy.

JOURNAL OF MEDICAL ETHICS, published by the esteemed BMJ PUBLISHING GROUP, is a leading journal that has been pivotal in advancing the discourse on ethical issues in healthcare since its inception in 1975. This UK-based journal, with an ISSN of 0306-6800 and an E-ISSN of 1473-4257, is well-regarded for its high-quality, peer-reviewed articles that delve into the complex moral dimensions surrounding medical practices, health policies, and social sciences. With a commendable impact, JOURNAL OF MEDICAL ETHICS has achieved Q1 quartile rankings across multiple categories, including Arts and Humanities and Health Policy in 2023, reflecting its significant influence and relevance in the field—ranked #23 of 552 in Arts and Humanities (Miscellaneous) with a 95th percentile, and #26 in Health Policy with a 91st percentile. Researchers, professionals, and students alike can benefit from the journal's commitment to fostering a deeper understanding of ethical considerations vital to the medical community, although it currently does not offer open access options. The journal's comprehensive examination of issues, ethics, and legal aspects continues to make it an essential resource for those dedicated to shaping the ethical landscape of healthcare.

Asian Bioethics Review, published by SPRINGER, is a premier journal indexed with ISSN 1793-8759 and E-ISSN 1793-9453, dedicated to advancing discourse in the interdisciplinary field of bioethics across Asia and beyond. Established in 2015, this esteemed publication has rapidly gained recognition, achieving a Q1 ranking in Philosophy and Q2 in key categories such as Health Policy and Issues, Ethics and Legal Aspects in 2023. With its robust Scopus rankings highlighting its significance across diverse domains—including a remarkable 98th percentile ranking in Philosophy—the journal serves as a vital platform for researchers, ethicists, and policymakers to explore pressing ethical issues and contribute to policy development in health and social sciences. Although not open access, the journal ensures a wide reach through institutional subscriptions, making it an essential resource for students and professionals committed to ethical practices in healthcare. Set in the dynamic backdrop of Singapore, "Asian Bioethics Review" continues to shape the conversation around bioethical practices in the Asian context and globally.

Acta Bioethica is a pivotal open access journal published by the Universidad de Chile's Centro Interdisciplinario de Estudios Bioética, dedicated to the multidisciplinary exploration of bioethical issues in health policy and social sciences. Since its inception in 2000, the journal has fostered dialogue among researchers, professionals, and students, addressing the complexities of ethical practices in diverse health contexts. With an impressive commitment to accessibility, Acta Bioethica has become a vital resource for those engaged in understanding the ethics of healthcare in Latin America and beyond. Although currently ranked in the lower quartiles of Scopus in both health policy and social sciences, the journal is steadily gaining recognition for its unique contributions to bioethics. The journal accepts contributions in both English and Spanish, ensuring a wider reach and impact in the academic community. Located in Santiago, Chile, and active from 2007 to 2024, Acta Bioethica continues to be an essential platform for advancing research and discussions in the ever-evolving field of bioethics.